Modern weight loss medications or weight loss injections have gained attention for their role in diabetes treatment and weight management. They are injectable drugs that act on gut hormones to help reduce appetite, slow digestion, increase feelings of fullness, and support blood sugar control. They belong to a class of drugs known as GLP‑1 receptor agonists (glucagon‑like peptide‑1), or GLP-1s.
What is GLP‑1?
GLP‑1 (glucagon‑like peptide‑1) is a naturally occurring hormone released in the gut after eating. Its functions include:
- Boosting insulin production to maintain healthy blood sugar levels
- Slowing down digestion and gastric emptying
- Creating a feeling of fullness after meals
What are GLP-1s?
Originally developed for type 2 diabetes, GLP‑1 medications or GLP1-s have also been shown to support weight loss.
They include:
• Semaglutide: A GLP-1 receptor agonist (mimics the action of the natural GLP-1 hormone). Clinical studies show an average weight loss of around 15 percent of body weight.
Brand names include:
◦ Wegovy®
◦ Ozempic®
• Tirzepatide: A dual GLP-1/GIP receptor agonist. This medication additionally mimics GIP, which also influences insulin secretion and blood sugar regulation. This may contribute to greater weight reduction and better diabetes control. Clinical studies show weight loss of up to 20 percent or more.
Brand names include:
◦ Zepbound®
◦ Mounjaro®
How GLP‑1s Work
GLP‑1s act on the brain, gut, and stomach to help manage weight. They:
- Decrease appetite and cravings
- Increase satiety (fullness)
- Slow gastric emptying (food stays in the stomach longer)
- Reduce “food noise” (the mental urge to snack or graze)
GLP‑1 medications primarily help people eat less, making weight management more achievable. Beyond weight and diabetes management, research suggests potential benefits for reducing the risk of heart disease, stroke, fatty liver, and possibly dementia.
Hunger vs. Appetite
- Hunger: Physiological need to eat
- Appetite: Psychological desire to eat
GLP‑1s primarily target the appetite centers in the brain, which is especially helpful for those with cravings or binge eating disorder.
Forms and Administration
- These medications must never be used except under medical supervision
- Most GLP‑1 medications are injectables
- Dosing schedules: Daily or weekly, depending on the drug
- Medications are often titrated gradually to minimize side effects
Who Should Consider GLP‑1s
- Eligibility:
- BMI ≥ 30
- BMI ≥ 27 with weight-related comorbidities like diabetes, hypertension, or high cholesterol
- Lifestyle prerequisites:
- Attempted diet and exercise first
- Commitment to healthy eating, exercise, stress management, and hydration
- Willingness for long-term use
GLP‑1 medications are not short-term solutions. Stopping the medication can lead to weight regain, similar to other chronic medications like blood pressure or diabetes treatments.
Side Effects & Safety
Common Side Effects
The most common side effects of modern weight‑loss medications, including tirzepatide and semaglutide, are gastrointestinal symptoms, such as:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal pain or bloating
These occur because the drugs slow digestion and increase feelings of fullness, and they are typically most pronounced early in treatment or during dose increases.
Potential Serious Risks
Serious but less common risks include:
- Pancreatitis (inflamed pancreas): can cause severe belly pain and vomiting.
- Gallbladder problems: rapid weight loss can increase gallstone risk.
- Kidney problems: dehydration from vomiting or diarrhea may worsen kidney function in susceptible individuals.
- Low blood sugar (hypoglycemia): especially if used with other glucose‑lowering medications like insulin or sulfonylureas.
- Allergic reactions: severe swelling of the face, throat, mouth, or rash may occur and need urgent care.
Other Considerations
- The drugs slow gastric emptying, which helps with satiety but may worsen symptoms in people with gastrointestinal motility disorders.
- Ozempic face: This occurs not from the drug itself but rather when fat is lost from the face faster than the skin can tighten, resulting in a sagging or hollowed appearance. It is more common in older adults as the skin loses elasticity with age.
- Thyroid Cancer Risk: In animal studies, both semaglutide and tirzepatide caused thyroid C‑cell tumors in rodents. This has led to boxed warnings and contraindications for people with certain thyroid cancer histories. It is not yet clear if this risk applies to humans, and large clinical analyses have not shown a definite increase in thyroid cancer in patients using GLP‑1 receptor agonists overall. Because of this potential risk, these medications are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), where the risk for this type of cancer is genetically higher.
Who Should Not Take These Medications (Contraindications)
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- History of pancreatitis
- Severe gastrointestinal disease: e.g., gastroparesis (stomach does not empty food normally)
- Type 1 diabetes (Should not be used in patients with Type 1 diabetes. Insulin is needed to control this condition)
- Pregnancy or breastfeeding (insufficient safety data; avoid use)
- History of diabetic ketoacidosis (DKA)
- Severe renal impairment
The Role of Weight-Loss Medications
Modern weight-loss medications are a potent tool for improving health outcomes in eligible patients. However, they are not a replacement for healthy habits.
Your doctor will recommend these lifestyle changes to support the medication:
- Eating protein‑rich, high‑fiber foods to preserve muscle and support digestion.
- Staying hydrated to reduce nausea and constipation.
- Eating smaller, frequent meals to match the reduced appetite.
- Doing regular aerobic and strength exercise to maintain metabolism and muscle.
- Planned meals to ensure balanced nutrition.
Ultimately, whether a modern weight-loss medication is appropriate should be decided in consultation with your endocrinologist. These medications are not one-size-fits-all. An endocrinologist will evaluate your medical history, metabolic profile, weight-related conditions, expected benefits, and potential risks before recommending a specific option. Treatment selection, dose adjustments, duration of therapy, and monitoring for side effects are all part of an individualized plan developed together, alongside ongoing lifestyle modification and regular follow-up.